Liver Diseases Center

INSTITUTE
University Hospitals Digestive Health Institute

MEDICAL DIRECTOR
Pierre M. Gholam, MD
Pierre.Gholam@UHhospitals.org

SURGICAL DIRECTOR

KEY CONTACTS
Anthony Post, MD; S. Martin Cohen, MD; Madeline Murphy, CNP

APPOINTMENT LINE
For hospital transfers, please call 216-844-1111.

Coordinators and Contact Information
• For transplant referrals and intake, please call Pamela Diamond at 216-844-3689.
• For medical referrals to the Liver Diseases Center, please call Rhonda Wynn at 216-844-5387.
• For referrals for surgical treatment at the Liver Diseases Center, please call Linda Little at 216-844-0489, option 2.
• For hospital transfers, please call 216-844-1111.

Conditions Treated

Chronic hepatitis C infection
Non-alcoholic steatohepatitis (NASH)
Fatty liver disease
End-stage liver disease requiring liver transplantation
Cirrhosis of the liver
Hepatocellular carcinoma (primary liver cancer)
Cholangiocarcinoma (bile duct cancer)
Benign liver tumors (hemangioma, adenoma, FNH)

Therapies
Liver transplantation
Antiviral therapy for HCV infection
Surgical resection of malignant and benign liver tumors
Radiofrequency ablation for hepatocellular carcinoma
Transarterial chemoembolization (TACE) for hepatocellular carcinoma
Transarterial radioembolization (TARE/Y90) for hepatocellular carcinoma
Systemic chemotherapy for hepatocellular carcinoma

Liver Diseases Center
Chronic hepatitis B infection
Alcoholic liver disease
Primary biliary cholangitis
Primary sclerosing cholangitis
Hereditary hemochromatosis
Vascular liver disease (portal vein thrombosis, Budd-Chiari syndrome)
Alpha one antitrypsin deficiency
Wilson disease
Stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma
Antiviral therapy for hepatitis B
Clinical trials for reversal of liver fibrosis/cirrhosis, fatty liver disease, hepatitis C and liver cancer
Treatment of cholestatic liver disease
Genetic testing and counseling for inherited disorders of the liver
Phlebotomy and follow-up of hereditary hemochromatosis

Distinguishing Features
Expedited evaluation of candidacy for liver transplantation for the patients who are most ill
Multidisciplinary hepatobiliary tumor board, with broad participation from expert surgeons, hepatologists, medical oncologists, interventional radiologists, pathologists, radiation oncologists and palliative care specialists
Nationally and internationally published quality and outcomes data
Access to state-of-the-art treatment, including early-phase clinical trials for patients with liver cancer
One of the largest hepatitis C treatment clinics in the U.S., with more than 1,000 patients treated and cured in the last two years
Access to state-of-the-art clinical trials for all the latest investigational treatments for fatty liver disease
Access to first-ever clinical trials for reversal of cirrhosis and liver fibrosis
NIH-funded clinical and research program in alcoholic liver disease


About UH Cleveland Medical Center
At the core of University Hospitals’ $4 billion health system is UH Cleveland Medical Center, ranked among America’s best hospitals by U.S. News & World Report. UH Cleveland Medical Center is home to some of the most prestigious clinical and research programs in the nation, including cancer, pediatrics, women’s health, orthopedics, radiology, neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and genetics. Its main campus includes UH Rainbow Babies & Children’s Hospital, ranked among the top children’s hospitals in the nation; UH MacDonald Women’s Hospital, Ohio’s only hospital for women; and UH Seidman Cancer Center, part of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University.